European Medicines Agency (EMA) Recommends Multaq Use Should Be Restricted For Safety Reasons
European Medicines Agency (EMA) Recommends Multaq Use Should Be Restricted For Safety Reasons EMA Cites The Increased Risks Of Liver Injury, Lung Side Effects, And Cardiovascular Adverse Events http://www.drug-injury.com/druginjurycom/2011/09/multaq-safety-review-fda-ema-restriction-regulatory-action-drug-recall.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
Categories
- Articles 309
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4